Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026, tell me about this news in (https://www.manilatimes.net/2026/09/09/tmt-newswire/globenewswire/biocomposites-to-host-industry-symposium-and-present-new-stimulan-data-at-ebjis-msis-2026/2421231)

Biocomposites, a medical devices company specializing in bone and soft tissue infection management, announced its participation as a Platinum Sponsor at the 44th Annual Meeting of the European Bone & Joint Infection Society (EBJIS), held in collaboration with the Musculoskeletal Infection Society (MSIS) in Porto, Portugal, from September 17–19, 2026.Key highlights from the announcement include:

• Industry Symposium: Biocomposites will host a symposium titled “From Spine to Arthroplasty: What Infection Specialists Can Learn Across Disciplines” on September 17, 2026. Chaired by Professor Yvonne Achermann, the session gathers orthopedic and infectious disease specialistsincluding Mr. Abtin Alvand and Mr. Oliver Stokesto examine the role of local combination antibiotic delivery across various surgical disciplines.
• New STIMULAN® Research: The company will present a scientific poster titled “Antibacterial efficacy of antibiotic loaded calcium sulfate beads against Staphylococcus aureus biofilms on different orthopedic implant surfaces” (Poster EP176). The in-vitro study demonstrates that STIMULAN calcium sulfate beads, loaded with combination Gram-positive and Gram-negative antibiotics, eradicate early biofilms and significantly reduce mature S. aureus biofilms on titanium, stainless steel, and polyethylene implant surfaces.
• Regulatory Milestones: The findings reinforce the expanded European Medical Device Regulation (MDR) certification received by STIMULAN, establishing it as the only calcium matrix certified for mixing with combination antibiotics to deliver targeted, high-concentration therapy at the infection site and minimize the need for secondary revision surgeries.